CD4 and tuberculosis: When comparing the new guidelines with the scenario that 19% of HIV patients with CD4+ cell counts of 201–350 receive ART (crudely reflecting the current South African policy of providing ART to pregnant and TB co-infected HIV patients), our model explorations show there will still be a break-even point around 2026 (blue line figure 4A).